
Britain’s Competition and Markets Authority (CMA) has cleared Brookfield’s proposed acquisition of a minority stake in Scotia Gas Networks (SGN) without referring the $1.7 billion deal to a lengthy investigation, reported Reuetrs.
In August 2021 British energy company SSE agreed to sell its entire 33.3% stake in Scotia Gas Networks to a consortium of Canadian companies formed by the Ontario Teachers’ Pension Plan Board and Brookfield Super-Core Infrastructure Partners.
SGN supplies gas to more than 5 million homes in England, Wales, Scotland and the west of Northern Ireland. The company, created in 2005, was awarded funding by industry regulator Ofgen in 2014 to develop research projects for the UK’s gas sector.
Britain’s competition regulator cleared Brookfield’s latest transaction, having considered the deal does not merit a so-called Phase 2 investigation, which could take up to 24 weeks as an in-depth review of the markets involved is carried out in order to determine the probability of any significant loss of competition in the markets.
Brookfield, a Canadian corporation that includes asset management activities and investment in various sectors, is a frequent player in the energy sector, with investments in energy producers in Europe, South America, as well as the UK and Canada.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas